By expenditures
| Name | Title | Type |
|---|---|---|
| Lisa Baxter | Chief Financial-Administrative Officer | Auditee |
| James Lacroix | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 340631 | 2024 | 2025-01-30 | Cohnreznick LLP | $6.95M |
| 290825 | 2023 | 2024-02-16 | Cohnreznick LLP | $3.20M |
| 19656 | 2022 | 2022-12-20 | Cohnreznick LLP | $2.00M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 290825 | 2023 | 2024-02-16 | 945990 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 945989 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 945988 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 945987 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 945986 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 945985 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 945984 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 945983 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 945982 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 945981 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 945980 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 945979 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 945978 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 945977 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 369548 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 369547 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 369546 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 369545 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 369544 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 369543 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 369542 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 369541 | 2023-002 | Significant Deficiency | - | I |
| 290825 | 2023 | 2024-02-16 | 369540 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 369539 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 369538 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 369537 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 369536 | 2023-001 | Significant Deficiency | - | A |
| 290825 | 2023 | 2024-02-16 | 369535 | 2023-001 | Significant Deficiency | - | A |